341 results on '"Veedu, Rakesh N."'
Search Results
2. Nanoparticles-assisted aptamer biosensing for the detection of environmental pathogens
3. Oligonucleotides containing 2′-O-methyl-5-(1-phenyl-1,2,3-triazol-4-yl)uridines demonstrate increased affinity for RNA and induce exon-skipping in vitro
4. Rational Design of Chimeric Antisense Oligonucleotides on a Mixed PO–PS Backbone for Splice-Switching Applications.
5. Metallic nanostructure-based aptasensors for robust detection of proteins
6. Inhibition of survivin by 2'-O-methyl phosphorothioate-modified steric-blocking antisense oligonucleotides.
7. Development of a Novel DNA Oligonucleotide Targeting Low-Density Lipoprotein Receptor
8. Splice-Switching Antisense Oligonucleotides Targeting Extra- and Intracellular Domains of Epidermal Growth Factor Receptor in Cancer Cells
9. Evaluation of Chemically Modified Nucleic Acid Analogues for Splice Switching Application
10. Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development
11. DNAzymes: Expanding the Potential of Nucleic Acid Therapeutics
12. Aptamer-engineered (nano)materials for theranostic applications
13. Thiomorpholino oligonucleotides as a robust class of next generation platforms for alternate mRNA splicing
14. Aptamers as Therapeutic Tools in Neurological Diseases
15. Multifunctional and multitargeted nanoparticles for drug delivery to overcome barriers of drug resistance in human cancers
16. Antisense Oligonucleotide: A Potential Therapeutic Intervention for Chronic Kidney Disease
17. Phosphorothioate modification improves exon-skipping of antisense oligonucleotides based on sulfonyl phosphoramidates in mdx mouse myotubes
18. Photoligation of self-assembled DNA constructs containing anthracene-functionalized 2′-amino-LNA monomers
19. Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation
20. Antisense Oligonucleotide Modified with Disulfide Units Induces Efficient Exon Skipping in mdx Myotubes through Enhanced Membrane Permeability and Nucleus Internalization
21. The ghrelin receptor antisense long non-coding RNA, GHSROS, in prostate cancer growth and survival: 066
22. Locked nucleic acid-modified antisense oligonucleotides for enhanced exon skipping in Duchenne muscular dystrophy: O17
23. Sequence-dependent inhibition of cGAS and TLR9 DNA sensing by 2′-O-methyl gapmer oligonucleotides
24. Novel 3′-[4-fluoroaryl-(1,2,3-triazol-1-yl)]-3′-deoxythymidine analogues: Design, synthesis, characterization and their potential as anticancer agents.
25. How to Develop and Prove High-Efficiency Selection of Ligands from Oligonucleotide Libraries: A Universal Framework for Aptamers and DNA-Encoded Small-Molecule Ligands
26. Recent Advances in Oligonucleotide Therapeutics in Oncology
27. Antisense Oligonucleotides as Potential Therapeutics for Type 2 Diabetes
28. Evaluation of DNA segments in 2′-modified RNA sequences in designing efficient splice switching antisense oligonucleotides
29. Development of nucleic acid aptamer-based lateral flow assays: A robust platform for cost-effective point-of-care diagnosis
30. G-rich VEGF aptamer with locked and unlocked nucleic acid modifications exhibits a unique G-quadruplex fold
31. Nucleic Acid Aptamers as Novel Class of Therapeutics to Mitigate Alzheimer’s Disease Pathology
32. Locked Nucleic Acid Oligonucleotides toward Clinical Applications
33. Enzymatic synthesis of DNA strands containing α-L-LNA (α-L-configured locked nucleic acid) thymine nucleotides
34. Therapeutically Significant MicroRNAs in Primary and Metastatic Brain Malignancies
35. Novel Disulfide-Bridged Bioresponsive Antisense Oligonucleotide Induces Efficient Splice Modulation in Muscle Myotubes in Vitro
36. Development of Novel Chemically-Modified Nucleic Acid Molecules for Efficient Inhibition of Human MAPT Gene Expression
37. Author Correction: Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro
38. A systematic investigation of key factors of nucleic acid precipitation toward optimized DNA/RNA isolation
39. Alpha-l-Locked Nucleic Acid-Modified Antisense Oligonucleotides Induce Efficient Splice Modulation In Vitro
40. Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics
41. Consequences of Making the Inactive Active Through Changes in Antisense Oligonucleotide Chemistries
42. Development of nucleic acid aptamer-based lateral flow assays: A robust platform for cost-effective point-of-care diagnosis.
43. Efficient Epidermal Growth Factor Receptor Targeting Oligonucleotide as a Potential Molecule for Targeted Cancer Therapy
44. Development of Novel antimiRzymes for Targeted Inhibition of miR-21 Expression in Solid Cancer Cells
45. The long non-coding RNAGHSROSreprograms prostate cancer cell lines toward a more aggressive phenotype
46. Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro
47. Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics
48. The long non-coding RNA GHSROS facilitates breast cancer cell migration and orthotopic xenograft tumour growth.
49. Abstract 2452: Dysregulated expression of the human long noncoding RNAGHSROSmay influence prostate cancer progression and resistance to docetaxel
50. Self-assembling asymmetric peptide-dendrimer micelles – a platform for effective and versatile in vitro nucleic acid delivery
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.